Patient Guide: A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06962800
Status: 🟢 Enrolling Now
Condition: Primary Membranous Nephropathy
Phase: PHASE3

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Pontiac, Michigan
  • • The Bronx, New York
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) - Join Clinical Trial NCTNCT06962800

How to Join This Clinical Trial - NCTNCT06962800

Learn how to participate in this PHASE3 trial studying an investigational therapy for Primary Membranous Nephropathy. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Primary Membranous Nephropathy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Primary Membranous Nephropathy
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06962800 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90022 - United States

Status: RECRUITING

Clinical Research Site

Pontiac, Michigan 48341 - United States

Status: RECRUITING

Clinical Research Site

The Bronx, New York 10468 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Greenville, North Carolina 27834 - United States

Status: RECRUITING

Clinical Research Site

Dallas, Texas 75231-0929 - United States

Status: RECRUITING

Clinical Research Site

Buenos Aires, C1015ABO - Argentina

Status: NOT_YET_RECRUITING

Clinical Research Site

Westmead, New South Wales 2145 - Australia

Status: NOT_YET_RECRUITING

Clinical Research Site

Porto Alegre, Rio Grande do Sul 90610-001 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

Xichengqu Beijing, Beijing Municipality 100034 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Guiyang, Guizhou 550004 - China

Status: NOT_YET_RECRUITING

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Primary Membranous Nephropathy:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships